OLFM2
Noelin-2
Also known as: NOE2, NOE2_HUMAN, OlfC
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O95897
- Gene
- OLFM2
- Ensembl
- ENSG00000105088
- Chromosome
- 19
- Canonical length
- 454 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
- Subcellular location
- Nucleoplasm
- Secretome location
- Secreted in other tissues
OverviewNCBI Gene
Involved in positive regulation of smooth muscle cell differentiation. Acts upstream of or within protein secretion. Located in cytoplasm; extracellular region; and nucleoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
454 residues, UniProt reviewed canonical sequence.
>O95897|OLFM2
1 MWPLTVPPPL LLLLCSGLAG QTLFQNPEEG WQLYTSAQAP DGKCICTAVI PAQSTCSRDG
61 RSRELRQLME KVQNVSQSME VLELRTYRDL QYVRGMETLM RSLDARLRAA DGSLSAKSFQ
121 ELKDRMTELL PLSSVLEQYK ADTRTIVRLR EEVRNLSGSL AAIQEEMGAY GYEDLQQRVM
181 ALEARLHACA QKLGCGKLTG VSNPITVRAM GSRFGSWMTD TMAPSADSRV WYMDGYYKGR
241 RVLEFRTLGD FIKGQNFIQH LLPQPWAGTG HVVYNGSLFY NKYQSNVVVK YHFRSRSVLV
301 QRSLPGAGYN NTFPYSWGGF SDMDFMVDES GLWAVYTTNQ NAGNIVVSRL DPHTLEVMRS
361 WDTGYPKRSA GEAFMICGVL YVTNSHLAGA KVYFAYFTNT SSYEYTDVPF HNQYSHISML
421 DYNPRERALY TWNNGHQVLY NVTLFHVIST SGDPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against OLFM2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 168 nTPM
Expression across tissuesHPA
Tissue
- basal ganglia: 168 nTPM
- cerebral cortex: 166 nTPM
- amygdala: 158 nTPM
- hippocampal formation: 113 nTPM
- skin: 85 nTPM
- hypothalamus: 84 nTPM
Single-cell type
- oligodendrocyte progenitor cells: 225 nCPM
- astrocytes: 200 nCPM
- basal keratinocytes: 140 nCPM
- bergmann glia: 137 nCPM
- müller glia: 126 nCPM
- suprabasal keratinocytes: 122 nCPM
Immune cell
- eosinophil: 50 nTPM
- basophil: 21 nTPM
- T-reg: 17 nTPM
- naive CD4 T-cell: 14 nTPM
- naive CD8 T-cell: 9 nTPM
- memory CD4 T-cell: 7 nTPM
Brain region
- midbrain: 166 nTPM
- cerebral cortex: 154 nTPM
- medulla oblongata: 149 nTPM
- pons: 149 nTPM
- basal ganglia: 118 nTPM
- amygdala: 109 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.62
- gnomAD pLI
- 0.08
- gnomAD missense Z
- 2.34
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- positive regulation of smooth muscle cell differentiation
- protein secretion
- signal transduction
- regulation of vascular associated smooth muscle cell dedifferentiation
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of OLFM2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads OLFM2 as an antibody target. Whether an autoantibody or antibody against OLFM2 could matter depends on whether native OLFM2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
OLFM2 is annotated as secreted, so native OLFM2 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label OLFM2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...